New Atomizer Option Loaded with 100 mg of Pure CBD Hemp Oil and Organic Cannabis Terpenes
SAN DIEGO, May 25, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway LLC, the first hemp lifestyle network to offer phyto-cannabinoid botanical products, is adding a new option for vaping cannabidiol (CBD) with a new vaporizer cartridge loaded with 100 mg of pure CBD hemp oil and terpenes to its HempVAP® product line.
As part of a series of new Kannaway® products featuring natural terpenes, including “Kannaway® Essential Oils,” recently launched at the Company’s IGNITE! National Convention 2017 in Scottsdale, Az., the vape oil in Kannaway’s® new HempVAP® atomizer cartridge combines 100 mg of CBD made from Kannaway Pure™ hemp oil and is flavored with the terpenes alpha-Pinene, myrcene, limonene, and linalool for an all-natural botanical flavor.
“This new CBD hemp oil vaporizer cartridge stands apart from any other product in the marketplace,” said Kannaway® CEO Blake Schroeder. “The product features Kannaway Pure™ CBD hemp oil blended with terpenes from hemp. This creates a superior option for consumers looking to avoid unhealthy mixing agents, such as propylene glycol and polyethylene glycol that can be found in other products on the market.”
Available now in the Kannaway® online store, these new terpene-infused atomizers work with existing HempVAP® batteries/hardware. For more information on Kannaway®, click HERE to visit the Company website.
About Kannaway, LLC
Kannaway, LLC is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.